Literature DB >> 20932697

Moyamoya disease in children.

Jun-ichi Takanashi1.   

Abstract

Moyamoya disease is an uncommon cerebrovascular disease characterized by progressive steno-occlusive changes in the terminal internal carotid arteries (ICA) and their main branches, associated with the development of moyamoya vessels. The incidence of the disease is high in east Asia, especially in Japan and Korea. The familial form accounts for 10-15%. Moyamoya disease has two age distribution peaks at around 5 and 40years. Most pediatric patients exhibit transient ischemic attacks or infarction. Headache and involuntary movements are serious symptoms associated with pediatric moyamoya disease. MRI and MR angiography (MRA) are useful and non-invasive methods for diagnosing or monitoring moyamoya disease. Cerebral angiography is still the gold standard for a diagnosis, however, it is not mandatory when MRI and MRA show typical findings of moyamoya disease; steno-occlusive changes at the ends of ICA and an abnormal vascular network in the basal ganglia. Other MRI findings have been reported, including T2 shortening in the white matter, the ivy sign on fluid-attenuated inversion recovery (FLAIR) images, and medullary streaks on FLAIR or enhanced T1-weighted images.
Copyright © 2010 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20932697     DOI: 10.1016/j.braindev.2010.09.003

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  14 in total

1.  Diagnosis of moyamoya disease using 3-T MRI and MRA: value of cisternal moyamoya vessels.

Authors:  Takeshi Sawada; Akira Yamamoto; Yukio Miki; Ken-Ichiro Kikuta; Tomohisa Okada; Mitsunori Kanagaki; Seiko Kasahara; Susumu Miyamoto; Jun C Takahashi; Hidenao Fukuyama; Kaori Togashi
Journal:  Neuroradiology       Date:  2012-02-21       Impact factor: 2.804

2.  The collateral circulation in pediatric moyamoya disease.

Authors:  Gerasimos Baltsavias; Nadia Khan; Anton Valavanis
Journal:  Childs Nerv Syst       Date:  2014-11-07       Impact factor: 1.475

3.  Reversible diffusion weighted imaging hyperintensities during the acute phase of ischemic stroke in pediatric moyamoya disease: a case report.

Authors:  Goichiro Tamura; Satoshi Ihara; Nobuhito Morota
Journal:  Childs Nerv Syst       Date:  2016-03-14       Impact factor: 1.475

4.  Ivy Sign in Moyamoya Disease.

Authors:  Ali Kemal Sivrioglu; Muzaffer Saglam; Bulent Yildiz; Vania Anagnostakou; Osman Kizilkilic
Journal:  Eurasian J Med       Date:  2016-02

5.  Selective and superselective angiography of pediatric moyamoya disease angioarchitecture: the anterior circulation.

Authors:  Gerasimos Baltsavias; Anton Valavanis; Venko Filipce; Nadia Khan
Journal:  Interv Neuroradiol       Date:  2014-08-28       Impact factor: 1.610

6.  Hemodynamics and changes after STA-MCA anastomosis in moyamoya disease and atherosclerotic cerebrovascular disease measured by micro-Doppler ultrasonography.

Authors:  Hanako Morisawa; Takakazu Kawamata; Akitsugu Kawashima; Masataka Hayashi; Kohji Yamaguchi; Taku Yoneyama; Yoshikazu Okada
Journal:  Neurosurg Rev       Date:  2012-11-29       Impact factor: 3.042

7.  A rare case of pediatric moyamoya disease with reversible white matter lesions in a 3-year-old Chinese girl.

Authors:  Shi-Jun Li; Jie Xiong; Yu He; Yang-Yang Xiao; Ding-An Mao; Li-Qun Liu
Journal:  Childs Nerv Syst       Date:  2019-11-10       Impact factor: 1.475

Review 8.  Quantitative Digital Subtraction Angiography in Pediatric Moyamoya Disease.

Authors:  Jung-Eun Cheon
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

Review 9.  Research Progress of Moyamoya Disease in Children.

Authors:  Jianmin Piao; Wei Wu; Zhongxi Yang; Jinlu Yu
Journal:  Int J Med Sci       Date:  2015-07-03       Impact factor: 3.738

10.  Is there a role for treating inflammation in moyamoya disease?: a review of histopathology, genetics, and signaling cascades.

Authors:  Adam M H Young; Surya K Karri; Christopher S Ogilvy; Ninghui Zhao
Journal:  Front Neurol       Date:  2013-08-14       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.